Commentary · 21 Feb 2026
Conference abstractPublished 14 Jul 2016
Micro-RNAs, the new strategy in the diagnosis and treatment of melanoma
Zahedan University of Medical Sciences, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
MiRNAs are non-coding RNAs, which have different biological and pathological functions. MiRNAs have an important role as post-transcriptional regulators of gene expression in many physiological processes, including development, cell differentiation and cell signaling. MiRNA as modulators of gene expression programs operate in various diseases, especially cancer, by suppressing genes that are crucial for carcinogenesis. Thus, these compounds can be utilized as a potential biomarker for early diagnosis, prediction and treatment of diseases, especially cancer and its follow up. We used PubMed and Web of Science Core Collection search engines for the Melanoma MicroRNA expression profiling studies between the periods 2000 and 2015. Search terms âÂ?Â?miR, microRNA and MelanomaâÂ? were used. A miRNA ranking system was used that took the frequency of comparisons, direction of differential expression and the total sample size into consideration. We identified twenty-one miRNAs that were most consistently reported to be up-regulated and thirty-four miRNAs that were down-regulated. In the group of consistently reported microRNAs, miR-21 and miR- 210 were reported up-regulated in 3 studies. MiR-203 was found down-regulated in six studies, respectively, followed by miR-211 and mir-34a in four studies. MiR-17, miR-193b and mir-20a were reported some studies, but their expression were inconsistent. This review study of human Melanoma microRNA expression profiling studies would provide information on microRNAs with potential role as the biomarkers in malignant melanoma and in the development of novel strategies for disease prevention and therapy.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Mehran Panahi”
